Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

European Stocks Mostly Higher; BioNTech Weakens on Vaccine Supply Concerns

Published 12/04/2020, 03:42 AM
Updated 12/04/2020, 03:43 AM
© Reuters.

By Peter Nurse 

Investing.com - European stock markets traded mostly higher Friday, helped by increasing confidence of a U.S. stimulus package that is reinforcing the positive sentiment generated by the rollout of Covid-19 vaccines.

At 3:45 AM ET (0845 GMT), the DAX in Germany traded largely flat, the CAC 40 in France rose 0.4% and the U.K.'s FTSE index climbed 0.7%. 

Global stock markets have seen strong gains over the last few weeks, helped by investor optimism that vaccine developments will support a global recovery in 2021. Adding to the confidence is the idea that a bipartisan, $908 billion coronavirus relief plan is gaining traction in the U.S. Congress. 

On top of fiscal support, the European Central Bank is widely expected to increase its bond buying next week and the U.S. Federal Reserve is likely to adjust its guidance around its asset purchase scheme later in December.

Earlier Friday, German industrial orders rose more than expected in October, rising by 2.9% on the month, while September's figure was upwardly revised to an increase of 1.1%. 

" The increase at the start of Q4 lifted the level of new orders to 0.8% above its pre-virus level, pointing to significant upside to manufacturing production, which was still languishing some 10% below its pre-Covid level at the end of Q3," said Claus Vistesen, an analyst with Pantheon Macroeconomics, in emailed comments.

Talks between the EU and U.K. negotiators to secure a Brexit deal have continued Friday, but a U.K. government source warned chances for a breakthrough were receding while France said it would veto any deal if it is considered unsatisfactory to French interests.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In corporate news, BioNTech SE (NASDAQ:BNTX) stock fell 3% after its partner Pfizer (NYSE:PFE) said supply chain obstacles forced it to slash the 2020 production target of its Covid-19 vaccine by half.

AB Foods (LON:ABF) stock rose 2.1% after the retail group said it still expects to increase profits and revenue at its Primark unit despite the coronavirus-inspired lockdowns.

Later in the session the monthly U.S. official employment report will be in focus, and is expected to show an addition of 469,000 jobs for November, a slowdown from the 638,000 seen in October. 

Oil prices gained Friday after a group of leading producers agreed to continue restricting production given the severe hit to demand in the wake of the Covid-19 pandemic.

The Organization of the Petroleum Exporting Countries and Russia, a group known as OPEC+, agreed Thursday to ease production cuts by 500,000 barrels per day from January 2021, backing down from the original plans to raise output by 2 million barrels a day.

The group will also meet once a month to review conditions, but stated that any monthly increases will not be greater than 500,000 barrels per day. 

U.S. crude futures traded 2.2% higher at $46.62 a barrel, while the international benchmark Brent contract rose 2.1% to $49.74, with the two benchmarks heading for their fifth consecutive week of gains.

Elsewhere, gold futures rose 0.2% to $1,844.70/oz, while EUR/USD traded 0.2% higher at 1.2159, having hit a new 31-month high overnight.

 

Latest comments

And if markets will be red at the end of the session, ready with the article: market close flat amid COVID surging cases.... boring... also tough to comment since market ignore any fundamentals or real economy news, they can't find any justification other then stimulus or covid, one for the upside and the other for the downside, both still there anyway though
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.